Signal active
Organization
Contact Information
Overview
Xcell Biosciences is a San Francisco-based life science start-up company that is developing novel and disruptive systems for cell therapy development and production. Their proprietary technology enables fine control of primary cell phenotype and function, enabling an entirely new capability for optimizing efficacy and persistence of immune cell therapies.
About
Biotechnology, Medical, Manufacturing, Therapeutics, Health Diagnostics
2012
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Xcell Biosciences headquartered in United States, North America, operates in the Biotechnology, Medical, Manufacturing, Therapeutics, Health Diagnostics sector. The company focuses on Biotechnology and has secured $4.0B in funding across 100 round(s). With a team of 11-50 employees, Xcell Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Convertible Note - Xcell Biosciences, raised $100.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
5
1
0
$39.6M
Details
2
Xcell Biosciences has raised a total of $39.6M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2022 | Early Stage Venture | 27.5M | ||
2017 | Early Stage Venture | 12.0M |
Investors
Xcell Biosciences is funded by 16 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Xcell Biosciences | - | FUNDING ROUND - Xcell Biosciences | 12.0M |
Viking Global Investors | - | FUNDING ROUND - Viking Global Investors | 12.0M |
Xcell Biosciences | - | FUNDING ROUND - Xcell Biosciences | 100.0K |
Illumina Accelerator | - | FUNDING ROUND - Illumina Accelerator | 100.0K |
Recent Activity
There is no recent news or activity for this profile.